Prof. Yipeng Liu | Nephrology | Young Scientist Award
The First Affiliated Hospital of Shandong First Medical University | China
Author Profile
YIPENG LIU: A PIONEER IN NEPHROLOGY RESEARCH ⚕️
EARLY ACADEMIC PURSUITS 🎓
Born in October 1985, Dr. Yipeng Liu demonstrated an early aptitude for medicine. He pursued his medical education with dedication, ultimately earning a medical doctorate. His academic training laid the foundation for a distinguished career in nephrology, focusing on podocytopathies. With a keen interest in clinical and basic research, he gained extensive expertise in idiopathic membranous nephropathy. His strong academic background enabled him to make significant contributions to both research and clinical practice.
PROFESSIONAL ENDEAVORS 🌟
Dr. Liu holds the prestigious position of Chief Physician in the Nephrology Department at Shandong Provincial Qianfoshan Hospital. He is also a Professor, Research Fellow, and PhD Supervisor. His leadership roles extend to serving as the Deputy Director of the Shandong Kidney Disease Research Institute. Recognized as a Taishan Scholar Young Expert for two consecutive terms (2019 and 2025), Dr. Liu has played a crucial role in advancing nephrology research. His professional memberships in leading medical associations reflect his influence in the field.
CONTRIBUTIONS AND RESEARCH FOCUS ON NEPHROLOGY🔬
Dr. Liu’s research is centered on podocytopathies in nephrology, with a specialized focus on idiopathic membranous nephropathy. He made a groundbreaking contribution by proposing the optimal diagnostic cutoff value for anti-PLA2R antibodies in Chinese patients, revolutionizing the non-invasive diagnosis of the disease. Additionally, he identified the risk factors and pathogenic links of thrombotic events in idiopathic membranous nephropathy, which provided essential insights for targeted anticoagulation therapy. His work on serum predictive factors has also significantly improved prognostic assessments in nephrology.
IMPACT AND INFLUENCE ✨
Dr. Liu’s research has shaped nephrology diagnostics and treatment protocols. His findings on anti-PLA2R antibody thresholds have influenced clinical guidelines, improving non-invasive diagnostic strategies worldwide. His insights into thrombotic risks in membranous nephropathy have set the foundation for safer and more effective treatment protocols. He actively collaborates with leading researchers on multicenter observational studies, expanding his influence in global nephrology research.
ACADEMIC CITATIONS 📖
Dr. Liu’s extensive research has been recognized in numerous indexed journals. His published works have a high citation index in databases such as SCI and Scopus, reflecting his contributions to medical science. His collaborative work on primary membranous nephropathy continues to receive significant academic attention, reinforcing his role as a thought leader in nephrology research
LEGACY AND FUTURE CONTRIBUTIONS 🌟
Dr. Liu’s legacy is built on his impactful research and contributions to nephrology and kidney disease treatment. Through his role as a PhD supervisor, he mentors the next generation of medical researchers, ensuring the continued advancement of nephrology studies. His future research aims to further refine non-invasive diagnostic tools, improve treatment strategies for membranous nephropathy, and explore new biomarkers for kidney disease prognosis. His leadership in interdisciplinary kidney disease research will continue to drive medical advancements, reinforcing his status as a pioneer in nephrology.
PROFESSIONAL MEMBERSHIPS 👥
- Shandong Research Hospital Association Outstanding Young Scholar Branch - Standing Committee Member
- Shandong Medical Association Nephrology Branch - Member
- Shandong Medical Association Blood Purification Branch - Member
- Shandong Medical Doctor Association Nephrology Physician Branch - Member
- Shandong Medical Doctor Association Multidisciplinary Innovation in Kidney Diseases Professional Committee - Member
RESEARCH AND INNOVATIONS 🔮
ONGOING AND COMPLETED RESEARCH PROJECTS:
- Extensive work on serum biomarkers for idiopathic membranous nephropathy
- Multicenter observational studies on kidney diseases
- Research on thrombotic risk factors in nephrology
PUBLICATIONS AND CITATIONS:
- Multiple high-impact journal articles published in indexed journals
- Significant citation index in SCI, Scopus, and Web of Science
PATENTS AND INNOVATIONS:
- Research contributing to the development of non-invasive diagnostic tools
- Innovative approaches in renal disease treatment strategies
EDITORIAL AND CONSULTING ROLES:
- Peer reviewer for leading nephrology and medical journals
- Active consultant in nephrology research projects
AWARDS AND RECOGNITIONS 🏆
Dr. Liu has received multiple accolades, including:
- Taishan Scholar Young Expert (2019, 2025)
- Outstanding Young Scholar in medical research
- Recognized for excellence in nephrology research and innovation
NOTABLE PUBLICATIONS📑
"Serum BAFF levels are associated with the prognosis of idiopathic membranous nephropathy"
- Authors: Li, Z. , Chen, P. , Zhang, Y. , Liu, Y. , Zhao, N.
- Journal: Renal Failure
- Year: 2024
"Research progress on extracellular vesicles in the renal tubular injury of diabetic kidney disease"
- Authors: Li, S. , Zheng, S. , Li, J. , Ma, C. , Liu, Y.
- Journal: Frontiers in Endocrinology
- Year: 2023
"Research progress on exosomes in podocyte injury associated with diabetic kidney disease"
- Authors: Li, J. , Zheng, S. , Ma, C. , Li, W. , Liu, Y.
- Journal: Frontiers in Endocrinology
- Year: 2023
"Optimal Value for Serum Anti-PLA2R Antibody in Primary Membranous Nephropathy: A Multicenter Observational Study"
- Authors: Chen, J. , Jia, X. , Wei, X. , Wang, D. , Xu, D.
- Journal: American Journal of Nephrology
- Year: 2022
"Association of plasma neutrophil gelatinase-associated lipocalin with parameters of CKD–MBD in maintenance hemodialysis patients "
- Authors: Jia, X.-Y. , Wei, K. , Chen, J. , Liang, L.-M. , Xu, D.-M.
- Journal: Journal of Bone and Mineral Metabolism
- Year: 2021